Saara Ahmad Muddasir Khan

Dr. Saara Ahmad Muddasir Khan

Aga Khan University, Karachi, Sindh, Pakistan

Research Focus & Metrics

Academic Career Length

14Years (2013-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
7 December 2022 in Molecules
Verified
Journal Article
Open access
PDF file
FAFaiq Amin
Faiq Amin
Mahmoud A. A. IbrahimMahmoud A. A. Ibrahim
Mahmoud A. A. Ibrahim
SRSyed Rizwan-Ul-Hasan
Syed Rizwan-Ul-Hasan
SKSaima Khaliq
Saima Khaliq
GGGamal Gabr
Gamal Gabr
SASyed Hani Abidi
Syed Hani Abidi
Background: The current study utilizes in silico molecular docking/molecular dynamics to evaluate the binding affinity of apigenin and safranal with 5HT1AR/5HT2AR, followed by assessment of in vivo effects of these compounds on depressive and anxious behavior. Methods: The docking between apigenin and safranal and the 5HT1A and 5HT2A receptors was performed utilizing AutoDock Vina software, while MD and protein-lipid molecular dynamics simulations were executed by AMBER16 software. For in vivo analysis, healthy control (HC), disease control (DC), fluoxetine-, and apigenin-safranal-treated rats were tested for changes in depression and anxiety using the forced swim test (FST) and the elevated plus-maze test (EPMT), respectively. Results: The binding affinity estimations identified the superior interacting capacity of apigenin over safranal for 5HT1A/5HT2A receptors over 200 ns MD simulations. Both compounds exhibit oral bioavailability and absorbance. In the rodent model, there was a significant increase in the overall mobility time in the FST, while in the EPMT, there was a decrease in latency and an increase in the number of entries for the treated and HC rats compared with the DC rats, suggesting a reduction in depressive/anxiety symptoms after treatment. Conclusions: Our analyses suggest apigenin and safranal as prospective medication options to treat depression and anxiety.

30 September 2022 in Heliyon
Verified
Journal Article
Open access
SKSaara Ahmad Muddasir Khan
Saara Ahmad Muddasir Khan
AAArfa Azhar
Arfa Azhar
PTPrashant Tikmani
Prashant Tikmani
HRHamna Rafique
Hamna Rafique
AKAsra Khan
Asra Khan
HSHumera Saeed
Humera Saeed
Depression is one of the common psychiatric problems in growing world population caused by long-term stressful events that may trigger the down regulation of neurogenesis. The pathogenesis of depression initially relies on serotonin deficiency which is associated with depressive feelings. Tryptophan (TRP) depletion participate crucial role in inducing depressive symptoms. Long-term reduction of 5-HT may disseminate to high sensitivity of MDD and alters the level of BDNF. Some studies have also revealed the strong association between excessive neuroinflammation and BDNF levels, due the release of pro-inflammatory cytokines. The treatment approach through FDA approved medicine has their own merits and drawbacks. Therefore, herbal alternatives have recently garnered attention for their effectiveness against depression. However, evidence-based synergic effects of antidepressant with different herbal agents are limited. The purpose of this study was to assess the synergistic effects of two well-known herbs, chamomile and saffron, as an adjuvant therapy in patients with mild to moderate depression. The present study was study randomized, open, blinded trial and comprised of 120 participants randomly allocated to control (n = 60) and test (n = 60). After consent, the patient health questionnaire- 9 (PHQ-9) was filled to obtain depression scores. The test participants were received herbal tea sachets twice a day for one month (20 mg Chamomile and 1 mg Saffron/sachet) along with routine medicines, while control participants were received only allopathic medications. Blood samples were taken before and after the treatment. The depressive symptoms improved significantly with both treatments. The effect of herbs enhanced the efficacy of medications and significantly improved PHQ-9 scale and BDNF while reduced the inflammatory markers (CRP) and TRP level in plasma thereby increased the availability of TRP in brain. It has been concluded that the herbal adjuvant therapy produced long term improvement against depression and enhanced the efficacy of allopathic treatment.

12 August 2022 in Metabolic Brain Disease
Verified
Journal Article
Closed access
PDF file
SKSaara Ahmad Muddasir Khan
Saara Ahmad Muddasir Khan
SASaad Bilal Ahmed
Saad Bilal Ahmed
AKAsra Khan
Asra Khan
MWMuhammad Wasim
Muhammad Wasim
STSaiqa Tabassum
Saiqa Tabassum
AGAnwar-Ul-Hassan Gilani
Anwar-Ul-Hassan Gilani



27 October 2022 in PLOS ONE
Verified
Journal Article
Open access
PDF file
SKSaara Ahmad Muddasir Khan
Saara Ahmad Muddasir Khan
HRHamna Rafiq
Hamna Rafiq
AKAsra Khan
Asra Khan
PTPrashant Tikmani
Prashant Tikmani
ZBZehra Batool
Zehra Batool
SHSaida Haider
Saida Haider
Introduction: Diabetes mellitus is a chronic metabolic disorder with an increasing prevalence worldwide. Reduction in blood insulin level alters brain function by inducing oxidative stress with changes in dopamine and norepinephrine neurotransmission, ultimately leading to neuropsychological symptoms. The efficacy of currently available psychotropic drugs is not satisfactory. Therefore, this study was conducted to explore the beneficial effects of a combination of the natural herbs, saffron and chamomile, in treating diabetes and its resultant neuropsychological effects using a rodent model of diabetes mellitus.Method: The rats were randomly divided in to eight groups (n = 10), healthy control (HC), diabetic control (DC) and six groups of diabetic rats treated with various concentrations and combinations of saffron and chamomile. Diabetic treatment groups individually received methanolic extract and water decoction of chamomile (30 mg/kg) and saffron (10mg/kg) and their combined half doses (saffron 5mg/kg and chamomile 15mg/kg) for two weeks. Open field test (OFT) and forced swim test (FST) were used to measure the anxiolytic and antidepressant effects of herbs, respectively. Finally, biochemical, and neurochemical estimations were made.Results: The present study suggests the therapeutic effects of herbs especially in co-administrated decoction, against diabetes with improved antioxidant profile and enhanced levels of dopamine and norepinephrine. Anxiolytic and antidepressant effects were evident with improvements in the OFT and FST. Examination of the cortex of the diabetic group revealed cellular damage and tangle formation, which indicates advanced stages of dementia.Conclusion: This study shows that the use of a combination of saffron and chamomile improves diabetes control and reduces its related psychiatric effects.